Loss of Respiratory Syncytial Virus Antibody Functions During the Peak of the COVID-19 Pandemic Mitigation Measures.
J Pediatric Infect Dis Soc
; 12(10)2023 Oct 28.
Article
en En
| MEDLINE
| ID: mdl-37948599
Studies have linked respiratory syncytial virus (RSV) antibody-mediated phagocytosis and complement deposition to severe RSV infection in humans. This study shows waning of these antibody functions in women of childbearing age in 2020-2021 during the implementation of COVID-19 mitigation measures, in absence of RSV circulation. These functions could be explored as correlates of protection against severe RSV disease.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
J Pediatric Infect Dis Soc
Año:
2023
Tipo del documento:
Article
País de afiliación:
Canadá